--- title: "Duos Technologies Posts Upbeat Q2 Results, Joins Amylyx Pharmaceuticals, Weave Communications And Other Big Stocks Moving Higher On Tuesday" type: "News" locale: "en" url: "https://longbridge.com/en/news/296242511.md" description: "Duos Technologies shares surged 21.5% after reporting Q2 earnings of $1.37 per share and sales of $6.175 million, both beating analyst estimates. Despite the Nasdaq falling over 300 points, other major stocks like Amylyx Pharmaceuticals, Weave Communications, and Duolingo also gained significantly due to positive trial results, acquisition news, and analyst upgrades." datetime: "2026-08-18T14:11:06.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/296242511.md) - [en](https://longbridge.com/en/news/296242511.md) - [zh-HK](https://longbridge.com/zh-HK/news/296242511.md) --- # Duos Technologies Posts Upbeat Q2 Results, Joins Amylyx Pharmaceuticals, Weave Communications And Other Big Stocks Moving Higher On Tuesday U.S. stocks were lower, with the Nasdaq Composite falling over 300 points on Tuesday. Shares of **Duos Technologies Group Inc** (NASDAQ:DUOT) rose sharply as the company reported better-than-expected second-quarter financial results. Duos Technologies reported quarterly earnings of $1.37 per share which beat the analyst consensus estimate of 66 cents per share. The company reported quarterly sales of $6.175 million which beat the analyst consensus estimate of $4.900 million. Duos Technologies Group shares jumped 21.5% to $12.48 on Tuesday. Here are some other big stocks recording gains in today’s session. - **Amylyx Pharmaceuticals In**c (NASDAQ:AMLX) shares jumped 44.1% to $30.88 after the company announced topline results from LUCIDITY Phase 3 trial met its primary endpoint. - **Weave Communications Inc** (NYSE:WEAV) gained 31.6% to $7.30 after the company announced it will be acquired by Francisco Partners. - **Haemonetics Corp** (NYSE:HAE) surged 15.5% to $104.35 after the company announced it entered into a supply agreement with CSL Plasma. - **Kura Oncology Inc** (NASDAQ:KURA) gained 11.7% to $12.60. Kura Oncology recently reported better-than-expected second-quarter EPS results. - **Obsidian Therapeutics, Inc**. (NASDAQ:OBX) rose 11.2% to $19.50. - **Unusual Machines Inc** (NYSE:UMAC) gained 9.6% to $33.07. - A**ngel Studios Inc** (NYSE:ANGX) rose 9.3% to $5.15. - **Newsmax Inc** (NYSE:NMAX) gained 8.5% to $11.24. Newsmax recently reported better-than-expected quarterly financial results. - **Shift4 Payments Inc** (NYSE:FOUR) surged 7.4% to $47.58. - **Recon Technology Ltd** (NASDAQ:RCON) shares jumped 7.3% to $4.81. - **Targa Resources Corp** (NYSE:TRGP) shares rose 6.4% to $295.97 after the company announced new 20-year agreements for gathering, processing and downstream services to support ExxonMobil’s development of its Permian Basin acreage. - **Duolingo Inc** (NASDAQ:DUOL) shares gained 5.4% to $137.15 after DA Davidson upgraded the stock from Neutral to Buy rating and raised its price target on the stock from $130 to $160. - **Intuit Inc** (NASDAQ:INTU) gained 5.5% to $353.95. _Photo via Shutterstock_ ### Related Stocks - [DUOT.US](https://longbridge.com/en/quote/DUOT.US.md) - [AMLX.US](https://longbridge.com/en/quote/AMLX.US.md) - [WEAV.US](https://longbridge.com/en/quote/WEAV.US.md) - [DUOL.US](https://longbridge.com/en/quote/DUOL.US.md) - [.IXIC.US](https://longbridge.com/en/quote/.IXIC.US.md) - [HAE.US](https://longbridge.com/en/quote/HAE.US.md) - [KURA.US](https://longbridge.com/en/quote/KURA.US.md) - [OBX.US](https://longbridge.com/en/quote/OBX.US.md) - [UMAC.US](https://longbridge.com/en/quote/UMAC.US.md) - [ANGX.US](https://longbridge.com/en/quote/ANGX.US.md) - [NMAX.US](https://longbridge.com/en/quote/NMAX.US.md) - [FOUR.US](https://longbridge.com/en/quote/FOUR.US.md) - [RCON.US](https://longbridge.com/en/quote/RCON.US.md) - [TRGP.US](https://longbridge.com/en/quote/TRGP.US.md) - [XOM.US](https://longbridge.com/en/quote/XOM.US.md) - [INTU.US](https://longbridge.com/en/quote/INTU.US.md) - [FOUR-A.US](https://longbridge.com/en/quote/FOUR-A.US.md) ## Related News & Research - [39,241 Shares in Amylyx Pharmaceuticals, Inc. $AMLX Bought by GSA Capital Partners LLP](https://longbridge.com/en/news/296452266.md) - [AMLX Stock Soars as Amylyx GLP-1 Drug Succeeds in Late-Stage Trial](https://longbridge.com/en/news/296265581.md) - [B. Riley Financial Initiates Coverage on Weave Communications (NYSE:WEAV)](https://longbridge.com/en/news/296233563.md) - [Amylyx Says Phase 3 Trial of Avexitide For Post-Bariatric Hypoglycemia Met Main Goal](https://longbridge.com/en/news/296218787.md) - [AMLX: Avexitide achieved a 55% reduction in severe hypoglycemic events in PBH, with strong safety data](https://longbridge.com/en/news/296234006.md)